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Abstract
The purpose of our study was to retrospectively evaluate
the computed tomography (CT)/magnetic resonance
imaging features of epithelioid angiomyolipoma of the
liver (Epi-HAML), with pathology as a reference. We
reviewed the CT/MRI ﬁndings of six lesions of Epi-
HAML and found absence of adipose tissue in the
lesions. In addition, recognizing the imaging features of
no capsule, and hypervasularity with central punctiform
or ﬁliform vessels as a characteristic enhancement may
distinguish Epi-HAML from other hepatic tumors.
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Angiomyolipoma (AML) of the liver is an uncommon
benign tumor, with abundant fatty component that can
be easily diagnosed by CT or MRI. However, epithelioid
AML of the liver (Epi-HAML) is a rare tumor of
unpredictable behavior, that contains no or only a min-
imal amount of adipose tissue and is difﬁcult to distin-
guish from other hypervascular tumors [1–3]. Rare
reports of Epi-HAML diagnosed by CT and MRI are in
the literature. In this study, we analyzed six lesions of
Epi-HAML by CT and MRI, and described the imaging
features of the tumor in order to achieve a better
understanding of this disease.
Subjects and methods
All the six patients who had Epi-HAML were women,
aged 32–64 years with a median of 47 years. Epi-HAML
lesions had been examinated by CT/MRI because of
abdominal pain (n = 1), suspected gallbladder stone
(n = 1) or on routine health examination (n = 4). Of
the six patients, none had a history of cirrhosis or viral
hepatitis and none had tuberous sclerosis. All patients
were negative for HbsAg and a-fetoprotein (AFP) levels
were within normal ranges.
Spiral CT scans were performed in four patients with
Siemens Sensation 16-detect CT scanner. MRI was per-
formed in two patients with Siemens Sensation 1.5-Tmag-
netic resonance scanner. Contrast agents (80–100 mL) or
Gd-DTPA (gadolinium diethylene triamine penta-acetic
acid) of 15 mL were injected intravenously as a bolus, a
triphasic contrast-enhanced dynamic exploration during
the arterial, portal venous, and delayed phases was per-
formed.
All patients received liver biopsy or partial hepatic
resection. CT images of the four patients and MRI
images of the two patients were available for retrospec-
tive analysis and were compared with pathological ﬁnd-
ings by three experienced radiologists.
Results
Helical CT and MR imaging demonstrated an obvious
tumor in all patients. The location, size, fat-containing,
capsule, non-enhanced images as well as the enhanced
images are listed in Table 1. Four lesions were located in
the left lobe of the liver, one lesion was located in the
right lobe and one in the caudate lobe. The lesions ran-
ged from 5.0 to 9.5 cm in diameter. All masses were well-
defined and no fatty attenuation or tense was found on
CT or MRI. Late enhancement of a discrete capsule was
observed in one mass.
With regard to the four patients who underwent CT,
Epi-HAML was predominantly hypoattenuating to liver
on unenhanced images in three patients (Figs. 1A, 2A),
and isoattenuating in one patient with fatty liver disease
(Fig. 3A). At hepatic arterial phase CT, the masses were
heterogeneously hyperattenuating in all patients. CentralCorrespondence to: Jian-song Ji; email: jjstcty@sina.com
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punctiform or filiform vessels could be seen in three
lesions(arrows) (Figs. 1B, 2B). Thick and curved vessels
were present in two lesions. At portal venous and delayed
phase CT, two lesions with abundant central vessels were
hypoattenuating (Fig. 1C, D). One lesion with small
vessels was isoattenuating (Fig. 2C), whereas another
lesion with fatty liver disease without vessels was
hyperattenuating (Fig. 3C).
With regard to the two patients who underwent MRI,
the lesionswere hypointense onT1WIandhyperintense on
T2WI (Fig. 4A, B). On hepatic arterial phase T1-weighted
MR images, tumors were heterogeneously hyperintense to
liver in both patients (Fig. 4C). On portal venous and
delayed phase T1-weighted MR images, the two tumors
were hypointense to liver (Fig. 4D, E). Central punctiform
and filiform vessels could be seen in both lesions (arrows)
Fig. 1. 64-Year-old woman with epithelioid AML in caudate
lobe of liver (patient 1). A Non-enhanced CT scan shows
hypoattenuating lesion in segment. B Contrast-enhanced CT
scan shows inhomogeneous enhanced lesion with thickly
distorted vessels (arrow) in the arterial phase. C, D The lesion
is hypoattenuating in the portal venous/delayed phase.
Table 1. The location, size, fat-containing, capsule, unenhanced images and enhanced images of six cases of epithelioid hepatic AML (Epi-HAML)
Case no. Sex Age Location Size (cm) Fat Capsule Vessels in lesion Unenhanced CT/MR Enhanced CT/MR arterial
portal delayed
1 F 64 S1 6.0 No No Yes Hypo Hyper Hypo Hypo
2 F 43 S2, S3 7.0 No No Yes Hypo Hyper Iso Iso
3 F 56 S4 5.0 No No No Iso Hyper Hyper Hyper
4 F 40 S2, S3 9.5 No No Yes Hypo Hyper Hypo Hypo
5 F 46 S7, S8 5.2 No No Yes T1 hypo, T2 hyper Hyper Hypo Hypo
6 F 32 S2, S3 7.0 No Yes Yes T1 hypo, T2 hyper Hyper Hypo Hypo
Cases 1, 2, 3, and 4 underwent CT examination, whereas cases 5 and 6 underwent MRI examination
S segment, Hyper hyperattenuation/hyperintense, Hypo hypoattenuation/hypointense, Iso isoattenuation, T1 hypo hypointense on T1WI, T2 hyper
hyperintense on T2WI
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and discrete capsule enhancement was evident in one le-
sion (white arrows) (Fig. 4B–E).
Histologically, the tumor was almost exclusively
composed of epithelioid cells, with little fat and thick-
walled blood vessels (Figs. 3D, 4F). All the tumor cells
demonstrated positive immunostaining for HMB-45.
Discussion
AML is an uncommon tumor that is composed of blood
vessels and mature fat cells as well as smooth muscle
cells. However, there are atypical AMLs composed
almost exclusively of epithelioid cells with pronounced
abnormal blood vessels and with less or no lipocytes.
These atypical AMLs have been referred to as Epi-AML
[4]. The appearance of an Epi-AML has been reported in
the kidney but rarely in the liver [5]. Epi-HAML is prone
to occur in females, without specific symptoms; the
tumors were always found incidentally in health exam-
inations. With increasing size of tumor, some patients
may show symptoms caused by tumor compression [2, 6].
The imaging characteristics of HAML are correlated
with its histological components. The fat content of
typical HAMLs produces a characteristic appearance on
imaging studies, thereby enabling the preoperative dif-
ferentiation of typical HAMLs from other hepatic
tumors [7]. Previous literature showed most Epi-HAML
tumors were completely devoid of adipose tissue, so little
or no fatty attenuation or tense was observed on CT or
MRI images, which is a characteristic radiographic fea-
tures of Epi-HAML compared with that of typical
HAML. However, the low fat content of Epi-HAML
makes the diagnosis of these tumors difficult [1, 2, 4].In
our study, precontrast CT or MRI did not detect fatty
attenuation in any of the tumors, a result consistent with
previous reports.
On dynamic CT or MRI studies, all the tumors were
markedly enhanced in the arterial phase, suggesting that
Epi-AML is a hypervascular tumor. Most lesions (four)
decreased obviously in the portal venous/delayed phase.
These ﬁndings are compatible with hepatocellular car-
cinoma (HCC) [8]. The distinction between these lesions
Fig. 2. 43-Year-old woman with epithelioid AML in left lobe
of liver (patient 2). A Non-enhanced CT scan shows hypoat-
tenuating lesion in segment 2/3. B Contrast-enhanced CT
scan shows obviously enhanced lesion in the arterial phase;
filiform vessels (arrow) within the lesion is show in the arterial
phase image. C The lesion is isoattenuating in the portal
venous phase.
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by enhancement pattern can be difficult. However,
abundant central vessels, especially thickly distorted
vessels were observed in these lesions, which is a char-
acteristic radiographic features of Epi-HAML com-
pared with other hypervascular hepatic tumors [9]. The
other two lesions with small or no vessels continued
enhanced in the portal venous/delayed phase. These
lesions with prolonged enhancement pattern should be
differentiated from HCCs and cavernous hemangiomas
[10].
In our study, discrete capsule enhancement was
observed within one lesion on contrast MRI. According
to the pathology specimens and the literature [11], there
is no true capsule in Epi-AML, but in some large lesions,
intact or discrete pseudocapsule enhancement can be
observed, composed of the compressed liver parenchyma
and sparse fibrosis tissues with small vessels, resulting in
delayed enhancement on late phase. Additionally, a
capsule can be found in most HCCs(~70 % of HCCs
with a diameter >2 cm are encapsulated), so the margins
of HCC are more clear than those of Epi-AML in the
portal venous phase, a suggestive finding for correct
diagnosis.
Although typical AMLs were regarded as universally
benign tumors and often grow slowly, it is becoming
increasingly clear that Epi-AML should be regarded as
tumors of uncertain malignant potential. Recently, rare
cases of Epi-AML with tumor recurrence, and vascular
invasion were reported [12, 13]. Surgical resection
should be considered for all symptomatic patients.
Conservative management with close follow-up is sug-
gested in asymptomatic patients with small mass
(<5 cm) that are diagnosed through fine-needle aspi-
ration biopsy [14].
In summary, Epi-AML usually presents as a well-
deﬁned, low fat content and unencapsulated mass in an
asymptomatic woman. In addition, hypervascularity
with central punctiform or ﬁliform vessels is a char-
acteristic radiographic features for Epi-HAML. The
enhancement pattern is divided into two types, lesions
Fig. 3. 56-Year-old woman with epithelioid AML in left lobe
of liver (patient 3). A Non-enhanced CT scan shows isoat-
tenuating lesion in segment 4 with fatty liver disease. B
Contrast-enhanced CT scan shows obviously enhanced le-
sion in the arterial phase. C The lesion shows prolonged
hyperattenuating in the portal venous phase. D Microscopic
examination shows that the tumor is almost exclusively
composed of epithelioid cells.
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with abundant central vessels rapidly decreased and
lesions with small or no vessels demonstrated pro-
longed enhancement in the portal venous/delayed
phase.
Open Access. This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Tsui WM, Colombari R, Portmann BC, et al. (1999) Hepatic
angiomyolipoma: a clinicopathologic study of 30 cases and delin-
eation of unusual morphologic variants. Am J Surg Pathol 23:34–
48
2. Xu P-J, Shan Y, Yan F-H, Ji Y (2009) Epithelioid angiomyo-
lipoma of the liver: cross-sectional imaging findings of 10
immunohistochemically-verified cases. World J Gastroenterol
15(36):4576–4581
Fig. 4. 32-Year-old woman with epithelioid AML in left lobe
of liver (patient 6). A, B: MRI shows a well-defined tumor,
hypointense on T1-weighted and hyperintense on T2-weigh-
ted images in segment 2/3. C–E: Contrast-enhanced MRI
shows inhomogeneous enhanced lesion with punctiform or
filiform vessels (arrows) and discrete capsule enhancement
(white arrows). F Microscopically, the tumor consists of epi-
thelioid cells with no fat component. There is a thick-walled
blood vessel in the center (arrow).
J. Ji et al.: Epithelioid angiomyolipoma of the liver: CT and MRI features 313
3. Xie L, Jessurun J, Manivel JC, Pambuccian SE (2011) Hepatic
epithelioid angiomyolipoma with trabecular growth pattern: a mi-
mic of hepatocellular carcinoma on fine needle aspiration cytology.
Diagn Cytopathol. doi:10.1002/dc.21703
4. Alatassi H, Sahoo S (2009) Epithelioid angiomyolipoma of the
liver with striking giant cell component: fine-needle aspiration
biopsy findings of a rare neoplasm. Diagn Cytopathol 37(3):192–
194
5. Svec A, Velenska´ Z (2005) Renal epithelioid angiomyolipoma—a
close mimic of renal cell carcinoma. Report of a case and review of
the literature. Pathol Res Pract 200(11–12):851–856
6. Petrolla A, Xin W (2008) Hepatic angiomyolipoma. Arch Pathol
Lab Med 132:1679–1682
7. Hogemann D, Flemming P, Kreipe H, Galanski M (2001) Corre-
lation of MRI and CT findings with histopathology in hepatic
angiomyolipoma. Eur Radiol 11:1389–1395
8. Banshodani M, Ishiyama K, Amano H, Tashiro H (2009) Hepatic
angiomyolipoma with minimal intratumoral fat content. Case Rep
Gastroenterol 3:324–331
9. Xiao W, Zhou M, Lou H, Wang Z, Zhang M (2010) Hemody-
namic characterization of hepatic angiomyolipoma with least
amount of fat evaluated by contrast-enhanced magnetic resonance
angiography. Abdom Imaging 35(2):203–207
10. Ren N, Qin LX, Tang ZY, Wu ZQ, Fan J (2003) Diagnosis and
treatment of hepatic angiomyolipoma in 26 cases. World J Gas-
troenterol 9:1856–1858
11. Iannaccone R, Piacentini F, Murakami T, et al. (2007) Hepato-
cellular carcinoma in patients with nonalcoholic fatty liver disease:
helical CT and MR imaging findings with clinical-pathologic
comparison. Radiology 243:422–430
12. Nguyen TT, Gorman B, Shields D, Goodman Z (2008) Malignant
hepatic angiomyolipoma: report of a case and review of literature.
Am J Surg Pathol 32(5):793–798
13. Graziano A, Santangelo M, Umana DS (2008) Clinical evaluation
of epithelioid angiomyolipoma. Ann Ital Chir 79(2):135–138
14. Yang CY, Ho MC, Jeng YM, et al. (2007) Management of hepatic
angiomyolipoma. J Gastrointest Surg 11:452–457
314 J. Ji et al.: Epithelioid angiomyolipoma of the liver: CT and MRI features
